期刊文献+

原发性肝细胞癌RASSF1基因启动子甲基化检测及其临床意义 被引量:2

Methylation status of RASSF1 gene promoter in primary hepatocellular carcinoma and its clinical applications
下载PDF
导出
摘要 目的检测原发性肝细胞癌RASSF1基因启动子甲基化状态并探索其作为新的肿瘤生物标志物在肝细胞癌诊断中的意义。方法应用MSP和RT-PCR分别检测60例原发性肝细胞癌组织样本和癌旁组织RASSF1基因启动子甲基化状态和mRNA表达。结果 60例PHCC组织样本中有51例存在RASSF1基因启动子甲基化状态(85.0%),均检测不到mRNA表达,癌旁组织甲基化阳性率为5%,mRNA表达正常。RASSF1基因启动子甲基化与肿瘤病理分期和直径大小呈正相关关系,而与患者性别、年龄和血清AFP水平无关。结论 RASSF1基因启动子甲基化在PHCC的发病机制中起到重要作用,可以作为新的肿瘤生物标志物为PHCC诊断和评估提供重要分子线索。 【Objective】 To detect the methylation status of RASSF1 gene promoter in primary hepatocellular carcinoma(PHCC) and explore its biomarker role in the diagnosis of PHCC.【Methods】 MSP and RT-PCR were conducted to detect RASSF1 gene promoter's methylation status and its mRNA expression in PHCC and paracancerous tissues respectively.【Results】 51 in 60 PHCC tissues displayed positive methylation status(85.0%) with no mRNA expression,while it was 5% in paracancerous tissues with normal mRNA expression.RASSF1 gene promoter methylation positively correlated with clinical tumor staging and its size,while had nothing to with patients' gender,age and serum AFP levels.【Conclusions】 RASSF1 gene promoter hypermethylation may play a crucial role in the pathogenesis of PHCC,it could be served as a tumor biomarker and provide important molecular clues in the diagnosis and evaluation of PHCC.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第15期1864-1867,共4页 China Journal of Modern Medicine
关键词 RASSF1 原发性肝细胞癌 启动子 甲基化 RASSF1 primary hepatocellular carcinoma promoter methylation
  • 相关文献

参考文献1

二级参考文献10

  • 1Dammann R,Yang G,Pfeifer G P.Hypermethylation of the CPG island of Ras association domain family 1 A (RASSF1A), a Putative tumor suppressor gene from the 3P21.3 locus, occurs in a large percentage of human breast Cancer[].Cancer Research.2001
  • 2Dammann R,Li C,Yoon J H et al.Epigenetic inactivation of a Ras association domain family Protein from the Lung tumor suppressor Locus 3P21.3[].Net Genet.2002
  • 3Whang Y M,Kim Y H,Kim J S et al.RASSF1A sup- presses the C-Jun-NH2-kinase pathway and inhibits cell cycle progression[].Cancer Research.2005
  • 4Vos M D,,Martinez A,Elam C et al.A role for the RASSF1A tumor suppressor in the regulation of tublin polgmerization and genomic stability[].Cancer Research.2004
  • 5Cheng J C,Matsen C B,Gonzales F A et al.lnhibition of DNA methylation and reactivation of Silence genes by Zebularine[].Journal of the National Cancer Institute.2003
  • 6Spugnardi M,Tommasi S,Dammann R,et al.Epigenetic inactivation of Ras association domain family protein 1(RASSF1 A) in malignant cutaneous melanoma[].Cancer Research.2003
  • 7Undraga Schagdarsuregin,Oliver Gimm,Cuong Hoang-Vu,et al.Frequent Epigenetic Silencing of the CpG Island Promoter of RASSF1A in Thyroid Carcinoma[].Cancer Research.2002
  • 8Shivakumar L,Minna J,Sakamaki T,et al.The RASSF1 A tumor suppressor blocks cell cycle progression and inhibits cyclinD1 accumulation[].Molecular and Cellular Probes.2002
  • 9Michele DV,Chad AE,Aaron B,et al.Ras use the novel tumor suppressor RASSF1 as an effector to mediate apoptosis[].Journal of Biological Chemistry.2000
  • 10Dallol A,Agathanggelou A,Fenton SL, et al.RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics[].Cancer Research.2004

共引文献1

同被引文献21

  • 1赵中海,耿小平,朱立新,李晓明,刘宗石.肝细胞癌组织中RAS相关区域家族蛋白1A、肿瘤高甲基化基因1和P73基因的异常甲基化[J].中华外科杂志,2005,43(23):1528-1532. 被引量:6
  • 2刘晓红,周航波,马恒辉,周志毅,陆珍凤,周晓军.肝细胞肝癌中Wnt5a、β-catenin和E-cadherin蛋白的表达及临床意义[J].临床与实验病理学杂志,2007,23(4):400-403. 被引量:13
  • 3Siegel R, Naishadham D, Jemal A. Cancer statistics [ J ]. CA Cancer J Clin, 2013, 63(2) :11-30.
  • 4Nishida N, Nagasaka T, Nishimura T, et al. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepati- tis, and hepatocellular carcinoma[J] Hepatology, 2008,47(3) :908-918.
  • 5Lou C, Du Z, Yang B, et al. Aberrant DNA methylatian profile of hepatocellular carcinoma and surgically resected margin[J]. Canc- er Sci, 2009, 100(6) :996-1004.
  • 6Zhang YJ, Ahsan H, Chen Y, et al. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to afla- toxin B1-DNA adduct levels in human hepatocellular carcinoma [J]. Mol Carcinog, 2002,35:85-92.
  • 7Feng QH, Stern JE, Hawes SE, et al. DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection[J]. Exp Mol Pathol, 2010,88(2) :287-292.
  • 8Saelee P, Wongkham S, Chariyalertsak S, et al. RASSF1A promot- er hypermethylation as a prognostic marker for hepatocellular carci- noma[J]. Asian Pac J Cancer Prey, 2010, 11(3) :1677-1681.
  • 9Zhang X, Li HM, Liu Z, et al. Loss of heterozygosity and methyla- tion of multiple tumor suppressor genes on chromosome 3 in hepato- cellular carcinoma[ J]. J Gastroenterol, 2013,48 (3) : 132-143.
  • 10Lee SLH, Kim JH, Lee HS, et al. Aberrant CpG Island Hyperm- ethylation Along Multistep t-Iepatocarcinogenesis [ J ]. AJP, 2003, 163(4) :1371-1378..

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部